After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) candidate from a clinical…

Disc Medicine has finalized the design of the confirmatory trial for its rare blood disorder drug candidate, adding a co-primary endpoint…

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well…

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look…

Bladder cancer is a grave concern, with a staggering cure rate exceeding 90% when detected early. However, this disease presents…

Chinese biotechs InnoCare Pharma and KeyMed Biosciences have sold the international rights to a clinical-stage bispecific antibody to a new…

Researchers at the Autism Research Centre at Cambridge University have uncovered significant disparities in healthcare experiences among autistic individuals who…

The landscape of prostate cancer management is undergoing a significant transformation as genomic classifier tests continue to gain attention for…

Dr. Park Jun-woo’s research team at the Korea Electrotechnology Research Institute (KERI) has made significant strides in the field of…

The Revival of Ancient Viral DNA: Unmasking Its Vital Role in Mammalian Embryo Development In recent decades, the field of…